Home LiteratureArticle Details
PMID: 1309286 Published · ppublish English Journal Article

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.

Annals of internal medicine ·Vol. 116 ·No. 2 ·1992-01-15 ·Pages 97-102

Simonetti RG, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Craxì A, Ciccaglione A, Giuseppetti R

Abstract

To determine whether chronic hepatitis C virus (HCV) infection is an independent risk factor for hepatocellular carcinoma and whether it increases the cirrhosis-related risk for hepatocellular carcinoma. Two pair-matched case-control studies. A referral-based hospital. In study I, 212 patients with hepatocellular carcinoma (197 of whom had known underlying cirrhosis) were compared with controls who had chronic nonhepatic diseases. In study II, the 197 patients with hepatocellular carcinoma and cirrhosis were compared with 197 pair-matched controls who had cirrhosis but not hepatocellular carcinoma. Levels of antibody to HCV (anti-HCV), hepatitis B surface antigen (HBsAg), and antibody to hepatitis B core antigen (anti-HBc) were assayed, and alcohol abuse was assessed by history. In study I, 151 patients (71%) with hepatocellular carcinoma were anti-HCV positive compared with 11 controls (5%) with chronic nonhepatic diseases (odds ratio, 42; 95% CI, 22 to 95). Multivariate analysis showed that anti-HCV was an independent risk factor for hepatocellular carcinoma (odds ratio, 69; CI, 15 to 308). The analysis also showed that HBsAg (odds ratio, 8.7; CI, 1.5 to 50) and anti-HBc (odds ratio, 4.2 (CI, 1.7 to 11) were risk factors for hepatocellular carcinoma. No statistically significant interaction was found between anti-HCV and the markers of HBV infection. In study II, 146 patients (74%) with hepatocellular carcinoma and cirrhosis were anti-HCV positive compared with 122 patients (62%) with cirrhosis alone (odds ratio, 1.8; CI, 1.1 to 2.8). Multivariate analysis confirmed that anti-HCV (odds ratio, 2.0; CI, 1.3 to 32) and HBsAg (odds ratio, 2.0; CI, 1.0 to 4.2) were independent risk factors for hepatocellular carcinoma. Hepatitis C virus infection is a risk factor for hepatocellular carcinoma, apparently by inducing cirrhosis and, to a lesser extent, by enhancing the risk in patients with cirrhosis. Hepatitis C virus infection acts independently of HBV infection (another risk factor) and of alcohol abuse, age, or gender.

MeSH Terms
Aged Carcinoma, Hepatocellular/etiology Case-Control Studies Female Hepacivirus/immunology Hepatitis Antibodies/blood Hepatitis B Antibodies/blood Hepatitis B Core Antigens/immunology Hepatitis B Surface Antigens/blood Hepatitis C/complications Humans Liver Cirrhosis/complications Liver Neoplasms/etiology Male Middle Aged Prevalence Risk Factors Sicily
Chemicals
Hepatitis Antibodies Hepatitis B Antibodies Hepatitis B Core Antigens Hepatitis B Surface Antigens
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Simonetti R G
Istituto di Medicina Generale e Pneumologia, University of Palermo, Italy.
Cammà C
Fiorello F
Cottone M
Rapicetta M
Marino L
Fiorentino G
Craxì A
Ciccaglione A
Giuseppetti R
Article Info
Journal
Annals of internal medicine
Abbr.
Ann Intern Med
ISSN
0003-4819
Published
1992-01-15
Pages
97-102
Language
English
Region
United States
NLM ID
0372351
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com